Infection-Related Malignant Neoplasm — Trials

Infection-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 71
Ph III recruiting: 2
Growth YoY: −24%
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07388563	Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma	suspended	Phase 1	20	National Cancer Institute (NCI)NIH	1	Aug 26, 2026	clinicaltrials
NCT05377827	Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies	suspended	Phase 1	6	Washington University School of MedicineOTHER	1	Jul 21, 2026